Pacira BioSciences, Inc. (PCRX)

26.25 +0.15 (+0.57%) At close: 04:00PM EDT

Pacira BioSciences, Inc.

5401 West Kennedy Boulevard
Suite 890
Tampa, FL 33609
United States
813 553 6680
https://www.pacira.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 711

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Charles A. Reinhart III, CPA, M.B.A.	Chief Financial Officer	780.58k	N/A	1961
Mr. Daryl Gaugler	Chief Operating Officer	778.77k	115k	1962
Ms. Kristen Williams J.D.	Chief Administrative Officer & Secretary	799.63k	857.7k	1974
Mr. Anthony Molloy III, Esq.	Chief Legal & Compliance Officer	581.41k	802.07k	1974
Mr. David M. Stack	Advisor	1.54M	4.37M	1950
Mr. Frank D. Lee	CEO & Director	N/A	N/A	1968
Ms. Lauren Bullaro Riker	Principal Accounting Officer & Senior VP of Finance	288.81k	196.6k	1979
Susan Mesco	Head of Investor Relations	N/A	N/A	N/A
Mr. Richard Kahr	Vice President of Human Resources	N/A	N/A	N/A
Dr. Jonathan Slonin M.D.	Chief Medical Officer	815.25k	N/A	1976

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Corporate Governance

Pacira BioSciences, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.